A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.
The best Bull and Bear pitches based on recency and number of recommendations.
yes, this company had some problems in the past (Aetna announced that it would restrict coverage of the leading product Acthar Gel). However the figures still encourage to take an outperformance view: Forward PE of 6, PEG 0.35. Very high ROE, Gross… More
Still waiting patiently for this zero to get to zero. Wasn't expecting it to take half a decade...
Read the most recent pitches from players about QCOR.DL.
Find the members with the highest scoring picks in QCOR.DL.
See what the Wall Street professionals think, according to their public statements and filings.